Five-Year Outcomes With Ranibizumab vs Photodynamic Therapy in Individuals With Polypoidal Choroidal Vasculopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Long-Term Results of Photodynamic Therapy or Ranibizumab for Polypoidal Choroidal Vasculopathy in LAPTOP Study
Br J Ophthalmol 2018 Aug 04;[EPub Ahead of Print], N Miyamoto, M Mandai, A Oishi, S Nakai, S Honda, T Hirashima, H Oh, Y Matsumoto, M Uenishi, Y KurimotoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.